Since infected cells and cancer cells have a significantly increased sugar requirement, patients with chronic inflammation or cancer first receive an intravenous injection of insulin and, once the blood sugar level has been substantially lowered, glucose (sugar) and the desired antibiotic or chemotherapeutic agent are administered at the same time. This is performed according to the same scientific principle as PET (positron emission tomography), which uses the increased sugar requirement of the diseased cells to visualize and locate tumors. With the intravenous administration of radioactively tagged sugar, which is then absorbed exclusively and specifically by the diseased cells, the PET can accurately show the size and location of tumors).
With the help of insulin potentiated therapy (IPT), the necessary antibiotics (for chronic bacterial diseases) or antivirals (for chronic viral diseases) are directed explicitly to the infected cells only - while at the same time protecting the healthy cells.
This allows us to achieve much higher effective levels of the medication within the diseased cells, intensify and considerably shorten the duration of therapy.